China Pharma Holdings, Inc. (CPHI) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 2M | 2.35T | 2.33M | 2.7M | 2.85M | 3.27M | 3.74M | 3.97M | 5.12M | 6M | 5.81M | 5.53M |
| Cash & Short-Term Investments | 168.47K | 294.32K | 294.32K | 625.03K | 412.69K | 626.88K | 718.69K | 739.34K | 838.88K | 1.42M | 1.37M | 901.91K |
| Cash Only | 168.47K | 267.63K | 267.63K | 625.03K | 412.69K | 626.88K | 718.69K | 739.34K | 838.88K | 1.42M | 1.37M | 901.91K |
| Short-Term Investments | 0 | 0 | 26.7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 257.92K | 290.67K | 285.91K | 317.15K | 367.95K | 281.07K | 406.87K | 298.94K | 390.99K | 728.31K | 397.16K | 367K |
| Days Sales Outstanding | 25.1 | 21.63 | 36.68 | 30.39 | 25.7 | 27.91 | 29.51 | 33.94 | 37.18 | 24.08 | 19.49 | 42.41 |
| Inventory | 1.5M | 1.62T | 1.67M | 1.68M | 1.98M | 2.27M | 2.5M | 2.82M | 3.68M | 3.73M | 3.77M | 3.91M |
| Days Inventory Outstanding | 1000K | 1000K | 189.01 | 149.56 | 150.14 | 184.25 | 151.02 | 144.56 | 203.17 | 154.78 | 173.47 | 280.56 |
| Other Current Assets | 0 | 379.87B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 80.41K |
| Total Non-Current Assets | 43.32M | 28.65T | 13.66M | 11.07M | 11.37M | 11.62M | 9.73M | 10.29M | 11.07M | 10.47M | 9.55M | 10.18M |
| Property, Plant & Equipment | 4.47M | 4.57T | 4.7M | 4.23M | 4.4M | 4.53M | 4.96M | 5.5M | 6.15M | 6.82M | 7.51M | 8.1M |
| Fixed Asset Turnover | 0.00x | 0.00x | 0.17x | 0.24x | 0.25x | 0.24x | 0.21x | 0.16x | 0.21x | 0.30x | 0.23x | 0.13x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 38.67M | 24.08T | 8.78M | 6.83M | 6.96M | 7.09M | 4.76M | 4.79M | 4.92M | 3.65M | 2.03M | 2.07M |
| Long-Term Investments | 180K | 180K | 180K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | -180K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 45.32M | 31T | 15.98M | 13.77M | 14.22M | 14.89M | 13.47M | 14.26M | 16.19M | 16.47M | 15.35M | 15.7M |
| Asset Turnover | 0.00x | 0.00x | 0.05x | 0.07x | 0.08x | 0.08x | 0.08x | 0.06x | 0.08x | 0.14x | 0.12x | 0.07x |
| Asset Growth % | 218.8% | 99999900% | 18.71% | -3.47% | -12.19% | -9.6% | -12.29% | -9.19% | -6.72% | -7.39% | -5.25% | -12.36% |
| Total Current Liabilities | 7.27M | 7.4T | 6.62M | 5.25M | 5.12M | 5.02M | 4.76M | 4.71M | 5.73M | 6.82M | 7.06M | 10.55M |
| Accounts Payable | 837.11K | 891.08K | 588.74K | 530.73K | 548.26K | 225.11K | 390.24K | 141.04K | 647.83K | 966.42K | 831.3K | 414.08K |
| Days Payables Outstanding | 51.05 | 63.31 | 63.12 | 44.12 | 27.35 | 23.79 | 15.09 | 17.55 | 44.25 | 37.1 | 28.13 | 46.18 |
| Short-Term Debt | 3.47M | 71.63B | 3.44M | 2.11M | 2.09M | 2.16M | 2.52M | 2.58M | 2.66M | 3.1M | 3.87M | 7.64M |
| Deferred Revenue (Current) | 61.75K | 0 | 120.91K | 77.68K | 114.44K | 162.21K | 24.92K | 101.06K | 112.36K | 90.51K | 172.11K | 61.33K |
| Other Current Liabilities | 978.97K | 7.33T | 2.47M | 1.6M | 1.6M | 1.59M | 24K | 20K | 16K | 1.26M | 8K | 375.35K |
| Current Ratio | 0.28x | 0.32x | 0.35x | 0.51x | 0.56x | 0.65x | 0.79x | 0.84x | 0.89x | 0.88x | 0.82x | 0.52x |
| Quick Ratio | 0.07x | 0.10x | 0.10x | 0.19x | 0.17x | 0.20x | 0.26x | 0.24x | 0.25x | 0.33x | 0.29x | 0.15x |
| Cash Conversion Cycle | 1000K | 1000K | 162.58 | 135.83 | 148.49 | 188.36 | 165.44 | 160.95 | 196.09 | 141.76 | 164.84 | 276.8 |
| Total Non-Current Liabilities | 851.92K | 859.35B | 867.99K | 2.05M | 2.13M | 2.12M | 2.18M | 2.14M | 2.17M | 2.19M | 2.18M | 804.97K |
| Long-Term Debt | 0 | 111.55B | 0 | 1.32M | 1.39M | 1.39M | 1.43M | 1.4M | 1.41M | 1.41M | 1.39M | 0 |
| Capital Lease Obligations | 92.29K | 111.55K | 128.26K | 0 | 0 | 0 | 0 | 0 | 20.01K | 39.91K | 58.79K | 77.55K |
| Deferred Tax Liabilities | 759.63K | 747.8B | 739.73K | 734.25K | 732.24K | 731.2K | 750.09K | 737.52K | 740.83K | 742.11K | 732.08K | 727.42K |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 8.12M | 8.26T | 7.49M | 7.3M | 7.25M | 7.14M | 6.94M | 6.85M | 7.9M | 9.01M | 9.24M | 11.35M |
| Total Debt | 3.56M | 3.57M | 3.57M | 3.43M | 3.51M | 3.59M | 4.01M | 4.06M | 4.17M | 4.63M | 5.39M | 7.79M |
| Net Debt | 3.39M | 3.3M | 3.3M | 2.8M | 3.09M | 2.96M | 3.29M | 3.32M | 3.33M | 3.21M | 4.02M | 6.89M |
| Debt / Equity | 0.10x | 0.00x | 0.42x | 0.53x | 0.50x | 0.46x | 0.61x | 0.55x | 0.50x | 0.62x | 0.88x | 1.79x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | 32.66x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | 28.88x |
| Interest Coverage | -42.92x | -53.10x | -26.09x | -18.31x | -27.03x | -40.18x | -31.77x | -28.87x | -21.68x | -23.52x | -10.74x | -3.31x |
| Total Equity | 37.2M | 22.74T | 8.49M | 6.46M | 6.97M | 7.75M | 6.53M | 7.41M | 8.29M | 7.45M | 6.11M | 4.35M |
| Equity Growth % | 433.79% | 99999900% | 30.11% | -12.78% | -15.95% | 3.93% | 6.83% | 70.21% | 77.59% | 73.77% | 115.56% | 8.15% |
| Book Value per Share | 8.67 | 999999.00 | 2.19 | 1.98 | 1.64 | 1.63 | 1.37 | 1.56 | 1.74 | 1.57 | 1.28 | 0.91 |
| Total Shareholders' Equity | 37.2M | 22.74T | 8.49M | 6.46M | 6.97M | 7.75M | 6.53M | 7.41M | 8.29M | 7.45M | 6.11M | 4.35M |
| Common Stock | 40.52K | 15.52B | 5.02K | 3.26K | 3.26K | 32.62K | 17.86K | 17.16K | 14.82K | 10.63K | 104.77K | 87.47K |
| Retained Earnings | -48.36M | -47.21T | -45.99M | -45.34M | -44.81M | -44.03M | -42.8M | -41.68M | -40.25M | -39.29M | -38.06M | -37.28M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 12.02M | 11.58T | 11.4M | 11.35M | 11.33M | 11.32M | 11.52M | 11.38M | 11.43M | 11.45M | 11.33M | 11.25M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |